(Q30386188)

English

AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

0 references

1 reference

based on heuristic

inferred from title

influenza vaccine

0 references

author name string

Catherine Caillet

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Fabienne Piras

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Marie-Clotilde Bernard

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Aymeric de Montfort

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Florence Boudet

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Frederick R Vogel

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Agnès Hoffenbach

7

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Catherine Moste

8

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Inca Kusters

9

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

1 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

3076-3079

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.050

7 January 2021

Effect of priming on subsequent response to inactivated influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.050

7 January 2021

Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.050

7 January 2021

FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10–11, 2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.050

7 January 2021

Response to a monovalent 2009 influenza A (H1N1) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.050

7 January 2021

Adjuvant is necessary for a robust immune response to a single dose of H1N1 pandemic flu vaccine in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.050

7 January 2021

Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.050

7 January 2021

Immunogenicity and Reactogenicity of Influenza A/New Jersey/76 Virus Vaccines in Normal Adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.050

7 January 2021

Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.050

7 January 2021

Immunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human use

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.050

7 January 2021

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.050

7 January 2021

An adjuvanted, low-dose, pandemic influenza A (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.050

7 January 2021

US puts flu vaccines on trial. Interview by Declan Butler

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.050

7 January 2021

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.050

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.02.050

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30386188&oldid=1564022664"